Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RTMS for Clinical High-risk Syndrome of Psychosis Based on Personalized Targets Using Magnetoencephalography

NCT06802952 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT06802952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06802952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RTMS for Clinical High-risk Syndrome of Psychosis Based on Personalized Targets Using Magnetoencephalography
Lead sponsor
Shanghai Mental Health Center
Phase
Not applicable
Overall status
Recruiting
Start date
February 7, 2025
Completion date
December 31, 2026
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical high-risk syndrome of psychosis